These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 20587746)

  • 1. Anticholinergic use in children and adolescents after initiation of antipsychotic therapy.
    Hong IS; Bishop JR
    Ann Pharmacother; 2010; 44(7-8):1171-80. PubMed ID: 20587746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuromotor Adverse Effects in 342 Youth During 12 Weeks of Naturalistic Treatment With 5 Second-Generation Antipsychotics.
    Carbon M; Kapoor S; Sheridan E; Al-Jadiri A; Azzo S; Sarkaria T; Kane JM; Saito E; Correll CU
    J Am Acad Child Adolesc Psychiatry; 2015 Sep; 54(9):718-727.e3. PubMed ID: 26299293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents.
    Correll CU; Manu P; Olshanskiy V; Napolitano B; Kane JM; Malhotra AK
    JAMA; 2009 Oct; 302(16):1765-73. PubMed ID: 19861668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined treatment of quetiapine with haloperidol in animal models of antipsychotic effect and extrapyramidal side effects: comparison with risperidone and chlorpromazine.
    Tada M; Shirakawa K; Matsuoka N; Mutoh S
    Psychopharmacology (Berl); 2004 Oct; 176(1):94-100. PubMed ID: 15083255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A retrospective comparison of BMI changes and the potential risk factors among schizophrenic inpatients treated with aripiprazole, olanzapine, quetiapine or risperidone.
    Lee SY; Park MH; Patkar AA; Pae CU
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):490-6. PubMed ID: 21146575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Second-generation antipsychotics cause weight gain in youths.
    Harv Ment Health Lett; 2010 Jan; 26(7):7. PubMed ID: 20217902
    [No Abstract]   [Full Text] [Related]  

  • 7. Switching antipsychotic medications: not enough, too often, or just right?
    Weiden PJ
    Am J Psychiatry; 2011 Sep; 168(9):882-4. PubMed ID: 21890800
    [No Abstract]   [Full Text] [Related]  

  • 8. Second-generation antipsychotics in major depressive disorder: update and clinical perspective.
    Chen J; Gao K; Kemp DE
    Curr Opin Psychiatry; 2011 Jan; 24(1):10-7. PubMed ID: 21088586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxicology and overdose of atypical antipsychotic medications in children: does newer necessarily mean safer?
    Dubois D
    Curr Opin Pediatr; 2005 Apr; 17(2):227-33. PubMed ID: 15800418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicenter, randomized, double-blind, placebo-controlled, 16-week study of adjunctive aripiprazole for schizophrenia or schizoaffective disorder inadequately treated with quetiapine or risperidone monotherapy.
    Kane JM; Correll CU; Goff DC; Kirkpatrick B; Marder SR; Vester-Blokland E; Sun W; Carson WH; Pikalov A; Assunção-Talbott S
    J Clin Psychiatry; 2009 Oct; 70(10):1348-57. PubMed ID: 19906340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of second-generation antipsychotic monotherapy in the rapid control of acute bipolar mania.
    Keck PE
    J Clin Psychiatry; 2005; 66 Suppl 3():5-11. PubMed ID: 15762829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Movement disorders in elderly users of risperidone and first generation antipsychotic agents: a Canadian population-based study.
    Vasilyeva I; Biscontri RG; Enns MW; Metge CJ; Alessi-Severini S
    PLoS One; 2013; 8(5):e64217. PubMed ID: 23696870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical antipsychotics for the treatment of disruptive behavior.
    Lohr WD; Honaker J
    Pediatr Ann; 2013 Feb; 42(2):72-7. PubMed ID: 23379410
    [No Abstract]   [Full Text] [Related]  

  • 14. Evidence-based use of second-generation antipsychotics in a state Medicaid pediatric population, 2001-2005.
    Pathak P; West D; Martin BC; Helm ME; Henderson C
    Psychiatr Serv; 2010 Feb; 61(2):123-9. PubMed ID: 20123816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjunctive use of atypical antipsychotics and anticholinergic drugs among patients with schizophrenia.
    Ren XS; Huang YH; Lee AF; Miller DR; Qian S; Kazis L
    J Clin Pharm Ther; 2005 Feb; 30(1):65-71. PubMed ID: 15659005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of arrest in persons with schizophrenia and bipolar disorder in a Florida Medicaid program: the role of atypical antipsychotics, conventional neuroleptics, and routine outpatient behavioral health services.
    Van Dorn RA; Andel R; Boaz TL; Desmarais SL; Chandler K; Becker MA; Howe A
    J Clin Psychiatry; 2011 Apr; 72(4):502-8. PubMed ID: 21527125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of discontinuation of atypical antipsychotic agents in the treatment of schizophrenia.
    Mullins CD; Obeidat NA; Cuffel BJ; Naradzay J; Loebel AD
    Schizophr Res; 2008 Jan; 98(1-3):8-15. PubMed ID: 17596914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of atypical antipsychotics in elderly patients with dementia.
    Tariot PN; Profenno LA; Ismail MS
    J Clin Psychiatry; 2004; 65 Suppl 11():11-5. PubMed ID: 15264966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antipsychotic-induced extrapyramidal syndromes. Risperidone compared with low- and high-potency conventional antipsychotic drugs.
    Schillevoort I; de Boer A; Herings RM; Roos RA; Jansen PA; Leufkens HG
    Eur J Clin Pharmacol; 2001 Jul; 57(4):327-31. PubMed ID: 11549212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing tolerability profile of quetiapine, risperidone, aripiprazole and ziprasidone in schizophrenia and affective disorders: a meta-analysis.
    Moteshafi H; Stip E
    Expert Opin Drug Saf; 2012 Sep; 11(5):713-32. PubMed ID: 22913713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.